SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection

被引：52

作者：

Bell, Robert M. ^{[1
]}

Yellon, Derek M. ^{[1
]}

机构：

[1] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England

来源：

LANCET DIABETES & ENDOCRINOLOGY | 2018年 / 6卷 / 06期

关键词：

OUTCOMES; EMPAGLIFLOZIN;

D O I：

10.1016/S2213-8587(17)30314-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：435 / 437

页数：4

共 16 条

[1] Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients [J].

Al Jobori, Hussein ;

Daniele, Giuseppe ;

Adams, John ;

Cersosimo, Eugenio ;

Triplitt, Curtis ;

DeFronzo, Ralph A. ;

Abdul-Ghani, Muhammad .

DIABETES OBESITY & METABOLISM, 2017, 19 (06) :809-813

[2]

[Anonymous], 2016, CIRCULATION, V134, P752

[3] Na+/H+ exchange inhibitors for cardioprotective therapy:: Progress, problems and prospects [J].

Avkiran, M ;

Marber, MS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) :747-753

[4] Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits [J].

Baartscheer, Antonius ;

Schumacher, Cees A. ;

Wust, Rob C. I. ;

Fiolet, Jan W. T. ;

Stienen, Ger J. M. ;

Coronel, Ruben ;

Zuurbier, Coert J. .

DIABETOLOGIA, 2017, 60 (03) :568-573

[5]

Bertero E, 2017, CARDIOVASC RES, DOI [10.1093/cvr/cvx149, DOI 10.1093/CVR/CVX149.]

[6] Regulation of Signal Transduction by Reactive Oxygen Species in the Cardiovascular System [J].

Brown, David I. ;

Griendling, Kathy K. .

CIRCULATION RESEARCH, 2015, 116 (03) :531-549

[7] Glucagon and heart in type 2 diabetes: new perspectives [J].

Ceriello, Antonio ;

Genovese, Stefano ;

Mannucci, Edoardo ;

Gronda, Edoardo .

CARDIOVASCULAR DIABETOLOGY, 2016, 15

[8] CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis [J].

Ferrannini, Ele ;

Mark, Michael ;

Mayoux, Eric .

DIABETES CARE, 2016, 39 (07) :1108-1114

[9]

Hammoudi N, 2017, CARDIOVASC DRUG THER, DOI [10.1007/s10557-017-6734-1, DOI 10.1007/S10557-017-6734-1.]

[10] Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications [J].

Heerspink, Hiddo J. L. ;

Perkins, Bruce A. ;

Fitchett, David H. ;

Husain, Mansoor ;

Cherney, David Z. I. .

CIRCULATION, 2016, 134 (10) :752-772

← 1 2 →